US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

265.49

-5.4400-2.01%

Volume:41.87K

Turnover:11.11M

Market Cap:2.91B

PE:31.07

High:272.86

Open:272.86

Low:262.35

Close:270.93

52wk High:275.23

52wk Low:182.08

Shares:10.95M

Float Shares:10.95M

Volume Ratio:1.34

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.04

PE(LYR):7.03

Loading ...

Overview Company News Filings

Neogenomics Announces Executive Leadership and Board of Directors Succession Plan

THOMSON REUTERS

Neogenomics: Current Chair Lynn Tetrault to Continue to Serve as Independent Director Until 2027 Annual Meeting and not Stand for Reelection Then

THOMSON REUTERS

Should Trial Data Validation Require Action From Veracyte (VCYT) Investors?

Simply Wall St.

How New Mass Spectrometry Workflows Will Impact Bruker Stock (BRKR)

Simply Wall St.

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $83,464.02

Alkermes (ALKS), What Is Behind The Fresh Attention?

Simply Wall St.

Veeva supporting transformation of medicine through AI, Barron’s reports

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy

New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector

U.S. Stocks on the MOVE-Snowflake, Cboe, Oracle

US Stocks on the MOVE-Veracyte, Staar Surgical, Corning

Bruker (BRKR) Receives a Buy from Leerink Partners

Veracyte announces new findings from Phase III NRG/RTOG 0815 trial

Veracyte Gains on Data Supporting Use of Prostate Cancer Test to Guide Treatment Decisions

Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis

Phase Iii Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

THOMSON REUTERS

Bruker Corporation : Leerink Partners Raises Target Price to $80 from $60

THOMSON REUTERS

Bruker Launches timsUltra AIP Workflow to Boost Protein Sequence Coverage in Proteomics Studies

Bruker Advances Functional Proteomics with Novel Timsultra Aip and Timsomni Workflows for Drug Discovery & Development and Disease Biology Research

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/FBT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":265.49,"timestamp":1791304133376,"preClose":270.93,"halted":0,"volume":41874,"delay":0,"changeRate":-0.020078987192263677,"floatShares":10950002,"shares":10950002,"eps":8.545272,"marketStatus":"Trading","change":-5.44,"latestTime":"10-06 12:30:50 EDT","open":272.855,"high":272.855,"low":262.35,"amount":11105702.10162,"amplitude":0.038774,"askPrice":265.61,"askSize":13,"bidPrice":265.43,"bidSize":16,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":270.93,"sharesOutstanding":11450002,"nav":266.33,"aum":2902997532.66,"bidAskSpread":0.000914,"preHourTrading":{"tag":"盘前","latestPrice":270.93,"preClose":270.93,"latestTime":"08:11 EDT","volume":4,"amount":1082.099,"timestamp":1791288685408,"change":0,"changeRate":0,"amplitude":0.007238},"postHourTrading":{"tag":"盘后","latestPrice":270.93,"preClose":270.93,"latestTime":"19:30 EDT","volume":18,"amount":4873.78,"timestamp":1791243000792,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.335787,"impliedVol":0.2367,"impliedVolPercentile":0.8606},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10950002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":1.335787,"shares":10950002,"dividePrice":0,"high":272.855,"amplitude":0.038774,"preClose":270.93,"low":262.35,"week52Low":182.08,"pbRate":"1.04","psRate":"701.31","week52High":275.23,"institutionHeld":0,"latestPrice":265.49,"committee":0.103448,"eps":8.545272,"divideRate":0,"volume":41874,"delay":0,"ttmEps":8.545272,"open":272.855,"prevYearClose":206.52,"prevWeekClose":266.44,"prevMonthClose":272.26,"prevQuarterClose":272.26,"fiveDayClose":272.58,"twentyDayClose":265.78,"sixtyDayClose":247.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673081286","title":"Neogenomics Announces Executive Leadership and Board of Directors Succession Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081286","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081286?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA1SFY57:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0106261612.USD","NEO","LU0012050646.USD","BK4121","BK4196","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008125","title":"Neogenomics: Current Chair Lynn Tetrault to Continue to Serve as Independent Director Until 2027 Annual Meeting and not Stand for Reelection Then","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008125","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673008125?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA1SFY57:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","FBT","LU0106261612.USD","NEO","BK4121","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673870233","title":"Should Trial Data Validation Require Action From Veracyte (VCYT) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673870233","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673870233?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:15","pubTimestamp":1791191754,"startTime":"0","endTime":"0","summary":"Veracyte reported new data from a retrospective ancillary analysis of the phase III NRG/RTOG 0815 trial, showing that its Decipher Prostate Genomic Classifier helped identify which intermediate-risk prostate cancer patients in the study benefitted most from adding short-term androgen deprivation therapy to dose-escalated radiation. The results were presented at the 2026 ASTRO Annual Meeting.\nThe findings provided Level 1B1 prognostic and predictive evidence in a 395-patient cohort,...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/should-trial-data-validation-require-action-from-veracyte-vc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/should-trial-data-validation-require-action-from-veracyte-vc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ISBC","VCYT","FBT","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672720083","title":"How New Mass Spectrometry Workflows Will Impact Bruker Stock (BRKR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672720083","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672720083?lang=en_us&edition=fundamental","pubTime":"2026-10-04 18:17","pubTimestamp":1791109073,"startTime":"0","endTime":"0","summary":"In late September 2026, Bruker announced new timsUltra AIP and timsOmni workflows that expand mass spectrometry use across proteomics, glycoproteomics, structural biology and oligonucleotide analysis, alongside a US$6 million plus multi system NMR order from UC Berkeley.\nThe multi enzyme dia PASEF methods and ProteoScape links between discovery and targeted assays point to deeper integration of Bruker hardware, software and workflows in high value research and biopharma applications.\nThis...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/how-new-mass-spectrometry-workflows-will-impact-bruker-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/how-new-mass-spectrometry-workflows-will-impact-bruker-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","GXDW","LU0757428866.USD","LU1815336091.USD","VGFPF","JOYT","FEBU","RGLO","PMDE","TINY","VOTE","BK4121","BRKR","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672974104","title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $83,464.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2672974104","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672974104?lang=en_us&edition=fundamental","pubTime":"2026-10-03 06:23","pubTimestamp":1790979782,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin disposes of 2,034 common shares worth $83,464.02Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on Oct. 2, 2026.Sale price USD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6fSlzc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $83,464.02","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","PSIL","MEDX","IBRN","BK4139","PSCH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235796","title":"Alkermes (ALKS), What Is Behind The Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235796","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235796?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:21","pubTimestamp":1790904114,"startTime":"0","endTime":"0","summary":"Alkermes (NasdaqGS:ALKS) is back on investors’ radar after releasing phase 1 proof of concept data for ALKS 7290 in adults with ADHD, showing clinically meaningful symptom improvements and supportive safety findings.\nRecent trading tells a mixed story for Alkermes. The share price is around $40.54, with a 30 day share price return down 14.11% and a 90 day move lower by 25.72%. Yet the year to date share price return is up 43.45% and the 1 year total shareholder return sits at 29.69%,...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","FBT","MEDX","PSIL","PSCH","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672579387","title":"Veeva supporting transformation of medicine through AI, Barron’s reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2672579387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672579387?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:55","pubTimestamp":1790859332,"startTime":"0","endTime":"0","summary":"AI holds the promise to accelerate drug development, optimize clinical trials, and bring lifesaving therapies to market faster, and Veeva (VEEV) Sy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veeva-supporting-transformation-of-medicine-through-ai-barrons-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veeva-supporting-transformation-of-medicine-through-ai-barrons-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4534","BK4528","LU0106261372.USD","VTHR","AIPO","LU0006306889.USD","BK4504","VEEV","BK4613","GDOC","LU1989764664.SGD","CHAT","EKG","LU0058720904.USD","BK4585","BMED","LU0266013472.USD","MEDX","LFSC","QTOC","LU0289739699.SGD","ARTY","AGIX","FBT","LGHT","LU1989764748.USD","NVIB","BK4167","HYLG","LU0170899867.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672983731","title":"Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672983731","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672983731?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:18","pubTimestamp":1790828280,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has provided an announcement. Arovella Therapeutics is advancing an iNKT cell therapy platform aimed at...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-nears-first-patient-dosing-in-pivotal-ala-101-cell-therapy-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-nears-first-patient-dosing-in-pivotal-ala-101-cell-therapy-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","BK4585","BK4588","TBXU","FBT","IBBQ","LABX","GNOM","LFSC","SYNB","IBB","ALA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671520485","title":"MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2671520485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671520485?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:10","pubTimestamp":1790770233,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced that its clinical-stage agenT-797 iNKT platform has been selected as a therapeutic cell system within an Advance...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-selected-for-arpa-h-funded-initiative-to-advance-room-temp-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-selected-for-arpa-h-funded-initiative-to-advance-room-temp-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNCR","BK4588","LFSC","FBT","BK4585","TBXU","INKT","SYNB","GNOM","IBB","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671117244","title":"New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2671117244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671117244?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:43","pubTimestamp":1790707417,"startTime":"0","endTime":"0","summary":"How hot are biotech stocks? One of the bellwethers for the industry, the iShares Biotechnology ETF ($IBB) (left chart), has gained over 24% year to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVIB","XLK","PTH","BK4550","BK4585","BIOY","FBT","FDN","JHMH","XBIX","IBB","RXL","BIS","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671245927","title":"U.S. Stocks on the MOVE-Snowflake, Cboe, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2671245927","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671245927?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:53","pubTimestamp":1790697222,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Cboe, OracleSept 29 (Reuters)-The benchmark S&P 500 was flat on Tuesday, as rising government bond yields hurt risk sentiment and offset gains in AI-related sto","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL6N45L0Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BE","EGGY","SORCLmain","ORCL","STAA","UPGR","SNOY","SNOW","AIR","CVNY","FBT","ORCS","COIN","GLW","COYY","WLK","CABO","PEP","T","VOR","BKCH","ZAP","SSTI","XDAT","FTCI","FCEL","QURE","CLIX","FMCC","EFX","URI","09311","VVV","FNMA","CVNX","WRBY","WBD","GRML","CVNA","FICO","AMAT","DAPP","VCYT","BLMN","CCL","PWP","KMX","PLUG","DXST","PIPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671217890","title":"US Stocks on the MOVE-Veracyte, Staar Surgical, Corning","url":"https://stock-news.laohu8.com/highlight/detail?id=2671217890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671217890?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:17","pubTimestamp":1790687839,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Veracyte, Staar Surgical, CorningSeptember 29 (Reuters)-Wall Street's main indexes were set to open higher on Tuesday, helped by a pullback in oil prices, while media report","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL6N45L0O0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","07311","FIAT","ICOI","COIN","IE00BN8TJ469.HKD","LU0052756011.USD","CONL","COIA","COIX","LU1894683348.USD","LU0098860793.USD","BK4588","LU1571399168.USD","BK4177","LU2322448791.USD","GRML","COYY","LU1548497426.USD","DAPP","BLCK","COIW","LU1992135472.HKD","BK4516","LU2272731782.SGD","T","IE000F7OJYX1.SGD","IE00B19Z4B17.USD","FBT","CNAV","GLWG","LU0348723411.USD","LU2265009873.SGD","LU1621768206.USD","LU0149725797.USD","LU2272731865.HKD","BK4214","BK4539","LU0980610538.SGD","BK4600","IBLC","FINX","LU1861559042.SGD","IYZ","LU1430594728.SGD","BK4115","LU0130102774.USD","LU1621767737.EUR","FTXG","LU2543165471.USD","LU1720051017.SGD","BK4139","LU0310800965.SGD","PEP","LU2473716301.USD","BK4504","09711","LU0477156953.USD","LU1861558580.USD","IE0000B7K699.USD","BK4550","LU2384288077.EUR","BK4533","BK4572","LU0128525689.USD","LU1861217088.USD","BK4535","BK4187","FDIG","BK4581","BK4512","COIG","LU0648001328.SGD","BK4595","LU0976567544.SGD","LU1236620750.USD","LU0320765646.SGD","LU1236620834.HKD","LU1861220207.SGD","LU0211326755.USD","IE0031619046.USD","BK4566","IE000SO60NU8.SGD","CONX","LU0234572021.USD","BK4551","BK4507","BK4585","LU1201861249.SGD","LU0496365809.HKD","LU1244550494.USD","IE00B7SZL793.SGD","LU1267930227.SGD","STAA","LU0130517989.USD","CONI","LU2322448957.HKD","LU1244550221.USD","BK4515","VCYT","LU2360107671.USD","IE00B3T34201.USD","LU1720051108.HKD","IE00BLSP4239.USD","09311","CRPT","LU2102340556.USD","BK4554","IE00BSNM7G36.USD","07711","BK4598","LU1929549753.HKD","LU1992135399.USD","VOR","LU1804176565.USD","LU1621768115.EUR","BK4198","LU1585245621.USD","WBD","IE00BFMHRM44.USD","GLW","COII","IE000WAW04H5.SGD","BK4108","IE000BZT7R73.USD","LU1621767810.EUR","IE00BBT3K403.USD","IE000MB6IJN5.SGD","LU1894683264.USD","IE00B66KJ199.SGD","BKCH","BK4125","CONY","IE00BLSP4452.SGD","LU0211326839.USD","RULE","LU2357305700.SGD","BITQ","BK4596","KMX","BK4148","AIR","LU2272731600.USD","BK4534","IE00BFXG1179.USD","BK4548","COIO","LU1162221912.USD","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671212918","title":"Bruker (BRKR) Receives a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2671212918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671212918?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:56","pubTimestamp":1790686560,"startTime":"0","endTime":"0","summary":"In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Bruker, with a price target of $80.00. Souda covers the H...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1815336091.USD","BRKR","FBT","BK4121","TINY","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214286","title":"Veracyte announces new findings from Phase III NRG/RTOG 0815 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214286","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214286?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:37","pubTimestamp":1790685458,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) announced that new findings from a retrospective ancillary analysis of the randomized phase III NRG/RTOG 0815 trial will be present...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veracyte-announces-new-findings-from-phase-iii-nrg-rtog-0815-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veracyte-announces-new-findings-from-phase-iii-nrg-rtog-0815-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VCYT","FBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211273","title":"Veracyte Gains on Data Supporting Use of Prostate Cancer Test to Guide Treatment Decisions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211273","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211273?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:14","pubTimestamp":1790684052,"startTime":"0","endTime":"0","summary":"BUZZ-Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions** Shares of diagnostics company VeracyteVCYT.Orise 1.6% to $45.94 premarket** Co says its Decipher test identified intermediate-risk prostate cancer patients most likely to benefit from adding hormone therapy to radiation** Prostate cancer is a cancer of the prostate gland; hormone therapy lowers hormones that can help tumors grow** Patients with intermediate/high Decipher scores saw an 8 percentage-point reduction in cancer spread at 10 years when hormone therapy was added, Veracyte says** About 44% of patients had low scores and saw no significant benefit from added hormone therapy** Findings are based on a retrospective analysis of 395 patients from a late-stage prostate cancer trial** As of last close, stock down ~23% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211928","title":"Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211928?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:05","pubTimestamp":1790683539,"startTime":"0","endTime":"0","summary":"Veracyte Decipher Prostate test predicts benefit of adding hormone therapy to radiation in Phase III trial analysisVeracyte flagged new Decipher Prostate test data from a retrospective analysis of the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL5NNL37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","FBT","BK4139","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","BK4585","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2210150020.SGD","VCYT","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211377","title":"Phase Iii Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211377?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3FLWLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VCYT","FBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671151942","title":"Bruker Corporation : Leerink Partners Raises Target Price to $80 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2671151942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671151942?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:51","pubTimestamp":1790679073,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU0757428866.USD","LU1815336091.USD","FBT","TINY","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239775","title":"Bruker Launches timsUltra AIP Workflow to Boost Protein Sequence Coverage in Proteomics Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239775?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:01","pubTimestamp":1790593277,"startTime":"0","endTime":"0","summary":"Bruker launches timsUltra AIP workflow to boost protein sequence coverage in proteomics studiesBruker unveiled new timsUltra AIP and timsOmni workflows aimed at deeper proteomics coverage, targeted va","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL6N0WqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TINY","BRKR","FBT","LU0757428866.USD","LU1815336091.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239267","title":"Bruker Advances Functional Proteomics with Novel Timsultra Aip and Timsomni Workflows for Drug Discovery & Development and Disease Biology Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239267?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA2KFDYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BRKR","LU1815336091.USD","LU0757428866.USD","BK4121","TINY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}